v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 21,005 $ 24,365
Trade accounts receivable, net of allowance for credit losses of $2 and $17, respectively 3,624 1,670
Inventories, current 3,332 4,020
Other current assets 1,142 826
Total current assets 29,103 30,881
Property, plant and equipment, net 3,759 4,085
Inventories, noncurrent 306 379
Other noncurrent assets 181 129
Total assets 33,349 35,474
Current liabilities    
Accounts payable 258 291
Income taxes payable 7  
Accrued expense 772 981
Contract liabilities 2,950 1,255
Other current liabilities 59 121
Total current liabilities 4,046 2,648
Contract liabilities, noncurrent 768 751
Warrants   10
Deferred tax liabilities, net 43 33
Total liabilities 4,857 3,442
Commitments and contingencies (Note 13)
Shareholders' equity    
Common stock, $0.0001 par value; 300,000,000 shares authorized as of June 30, 2026 and December 31, 2025, and 2,205,648 and 2,007,613 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively and no shares issued or outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital 99,762 98,371
Accumulated deficit (71,270) (66,339)
Total shareholders' equity 28,492 32,032
Total liabilities and shareholders' equity $ 33,349 $ 35,474